Cholinesterase inhibitors

SANDOZ 618 Pill - yellow capsule-shape, 18mm

Pill with imprint SANDOZ 618 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Sandoz Pharmaceuticals Inc.

Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Rivastigmine transdermal (Rivastigmine transdermal [ riv-a-stig-meen ])-SANDOZ 618-1.5 mg-Yellow-Capsule-shape

Rivastigmine transdermal
Generic Name: rivastigmine transdermal [ riv-a-stig-meen ]
Imprint: SANDOZ 618
Strength: 1.5 mg
Color: Yellow
Size: 18.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Cholinesterase inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00781-2614 (Discontinued)
Inactive Ingredients: Gelatin, Hypromelloses, Magnesium stearate, Microcrystalline cellulose, Ferric oxide red, Silicon dioxide, Titanium dioxide, Ferric oxide yellow,
Latest News
Related Drugs